Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001213900-23-036895
Filing Date
2023-05-05
Accepted
2023-05-05 16:15:34
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea178017-424b5_citiuspharma.htm 424B5 302287
2 GRAPHIC image_001.jpg GRAPHIC 13550
  Complete submission text file 0001213900-23-036895.txt   322258
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 424B5 | Act: 33 | File No.: 333-255005 | Film No.: 23894031
SIC: 2834 Pharmaceutical Preparations